. Bijvoet, The Lancet, 1975.

A. Habibi, J. Arlet, K. Stankovic, J. Gellen-dautremer, J. Ribeil et al., French guidelines for the management of adult sickle cell disease: 2015 update]. Rev Médecine Interne Fondée Par Société Natl Francaise Médecine Interne, pp.5-8, 2015.

N. Amoako, K. Asante, G. Adjei, G. Awandare, L. Bimi et al., Associations between Red Cell Polymorphisms and Plasmodium falciparum Infection in the Middle Belt of Ghana, PLoS ONE, vol.208, issue.12, p.112868, 2014.
DOI : 10.1371/journal.pone.0112868.s001

G. Edington and H. Lehmann, Sickle-cell trait and malaria in Africa, Bull World Health Organ, vol.15, pp.3-5837, 1956.

T. Bensinger and P. Gillette, Hemolysis in sickle cell disease, Arch Intern Med, 1974.

D. Sears, P. Anderson, A. Foy, H. Williams, and W. Crosby, Urinary iron excretion and renal metabolism of hemoglobin in hemolytic diseases, Blood, vol.28, issue.5, pp.708-733, 1966.

K. Wood and D. Granger, SICKLE CELL DISEASE: ROLE OF REACTIVE OXYGEN AND NITROGEN METABOLITES, Clinical and Experimental Pharmacology and Physiology, vol.100, issue.9, pp.926-958, 2007.
DOI : 10.1001/jama.289.9.1136

J. Haymann, K. Stankovic, P. Levy, V. Avellino, P. Tharaux et al., Glomerular Hyperfiltration in Adult Sickle Cell Anemia: A Frequent Hemolysis Associated Feature, Clinical Journal of the American Society of Nephrology, vol.5, issue.5, pp.756-61, 2010.
DOI : 10.2215/CJN.08511109

URL : https://hal.archives-ouvertes.fr/hal-00597593

N. Masera, L. Tavecchia, L. Pozzi, F. Riva, C. Vimercati et al., Periodic erythroexchange is an effective strategy for high risk paediatric patients with sickle-cell disease, Transfusion and Apheresis Science, vol.37, issue.3, pp.241-248, 2007.
DOI : 10.1016/j.transci.2007.09.005

Z. Aliyu, A. Tumblin, and G. Kato, Current therapy of sickle cell disease, Haematologica, 2006.

J. Bolaños-meade and R. Brodsky, Blood and marrow transplantation for sickle cell disease: Is less more?, Blood Reviews, vol.28, issue.6, pp.243-251, 2014.
DOI : 10.1016/j.blre.2014.08.001

K. Abbott, I. Hypolite, and L. Agodoa, Sickle cell nephropathy at end-stage renal disease in the United States: patient characteristics and survival, Clinical Nephrology, vol.58, issue.07, pp.9-15, 2002.
DOI : 10.5414/CNP58009

A. Morgan, D. Ceulaer, K. Serjeant, and G. , Glomerular function and hyperuricaemia in sickle cell disease., Journal of Clinical Pathology, vol.37, issue.9, pp.1046-1055, 1984.
DOI : 10.1136/jcp.37.9.1046

D. Jong, P. , S. Van-eps, and L. , Sickle cell nephropathy: New insights into its pathophysiology, Kidney International, vol.27, issue.5, pp.711-718, 1985.
DOI : 10.1038/ki.1985.70

M. Allon, Renal Abnormalities in Sickle Cell Disease, Archives of Internal Medicine, vol.150, issue.3, pp.501-505, 1990.
DOI : 10.1001/archinte.1990.00390150015003

L. Statius-van-eps, C. Pinedo-veels, G. De-vries, and J. De-koning, Nature of concentrating defect in sickle-cell nephropathy. Microradioangiographic studies, Lancet Lond Engl Feb, vol.281, issue.7644, pp.450-452, 1970.

F. Hatch, J. Culbertson, and L. Diggs, Nature of the Renal Concentrating Defect in Sickle Cell Disease*, Journal of Clinical Investigation, vol.46, issue.3, pp.336-381, 1967.
DOI : 10.1172/JCI105535

D. Black, The renal concentrating mechanism. Anglo-Ger Med Rev Dtsch-Engl Med Rundsch, pp.176-185, 1966.

G. Marchese, Critical observations on the countercurrent urinary concentration system. II. Anatomophysiological considerations]. Recenti Prog Med, pp.286-304, 1967.

J. Sands and H. Layton, The Physiology of Urinary Concentration: An Update, Seminars in Nephrology, vol.29, issue.3, pp.178-95, 2009.
DOI : 10.1016/j.semnephrol.2009.03.008

S. Maurel, S. Stojanovic, K. Avellino, V. Girshovich, A. Letavernier et al., Prevalence and Correlates of Metabolic Acidosis among Patients with Homozygous Sickle Cell Disease, Clinical Journal of the American Society of Nephrology, vol.9, issue.4, pp.648-53
DOI : 10.2215/CJN.09790913

B. Koeppen and P. Steinmetz, Basic Mechanisms of Urinary Acidification, Medical Clinics of North America, vol.67, issue.4, pp.753-70, 1983.
DOI : 10.1016/S0025-7125(16)31175-0

J. Arruda and N. Kurtzman, Mechanisms and classification of deranged distal urinary acidification, American Journal of Physiology-Renal Physiology, vol.239, issue.6, pp.515-523, 1980.
DOI : 10.1152/ajprenal.1980.239.6.F515

D. Eladari and R. Chambrey, Ammonium transport in the kidney, J Nephrol, vol.23, issue.16, pp.28-34, 2010.

D. Jong, P. De-jong-van-den, L. Berg, S. Van-eps, and L. , The Tubular Reabsorption of Phosphate in Sickle-Cell Nephropathy, Clinical Science, vol.55, issue.5, pp.429-463, 1978.
DOI : 10.1042/cs0550429

V. Raj, M. Freundlich, D. Hamideh, O. Alvarez, W. Seeherunvong et al., Abnormalities in renal tubular phosphate handling in children with sickle cell disease. Pediatr Blood Cancer, 2014.

N. Al-harbi, S. Annobil, F. Abbag, F. Adzaku, and W. Bassuni, Renal Reabsorption of Phosphate in Children with Sickle Cell Anemia, American Journal of Nephrology, vol.19, issue.5, pp.552-556, 1999.
DOI : 10.1159/000013518

O. Oladipo, E. Temiye, V. Ezeaka, and P. Obomanu, Serum magnesium, phosphate and calcium in Nigerian children with sickle cell disease, West African Journal of Medicine, vol.24, issue.2, pp.120-123, 2005.
DOI : 10.4314/wajm.v24i2.28180

E. Smith, K. Valika, J. Woo, O. Donnell, J. Gordon et al., Serum Phosphate Abnormalities in Sickle Cell Anemia, Experimental Biology and Medicine, vol.168, issue.2, 1981.
DOI : 10.3181/00379727-168-41269

D. Jong, P. De-jong-van-den, L. Berg, G. Sewrajsingh, H. Schouten et al., Statius van Eps LW. Beta-2-microglobulin in sickle cell anaemia. Evidence of increased tubular reabsorption, Nephron, vol.29, pp.3-4138, 1981.

M. Reynolds, Gout and hyperuricemia associated with sickle-cell anemia. Semin Arthritis Rheum, pp.404-417, 1983.
DOI : 10.1016/0049-0172(83)90020-3

J. Arlet, J. Ribeil, G. Chatellier, J. Pouchot, M. De-montalembert et al., Hyperuricemia in sickle cell disease in France]. Rev Médecine Interne Fondée Par Société Natl Francaise Médecine Interne, pp.13-20, 2012.

H. Diamond, A. Meisel, E. Sharon, D. Holden, and A. Cacatian, Hyperuricosuria and increased tubular secretion of urate in sickle cell anemia, The American Journal of Medicine, vol.59, issue.6, pp.796-802, 1975.
DOI : 10.1016/0002-9343(75)90465-9

B. Walker and A. F. , Uric in Sickle Acid Excretion Cell Anemia, JAMA: The Journal of the American Medical Association, vol.215, issue.2, pp.255-263, 1971.
DOI : 10.1001/jama.1971.03180150039008

D. Ceulaer, K. Morgan, A. Choo-kang, E. Wilson, W. Serjeant et al., Serum urate concentrations in homozygous sickle cell disease, Journal of Clinical Pathology, vol.34, issue.9, pp.965-974, 1981.
DOI : 10.1136/jcp.34.9.965

O. Peterson, L. Gushwa, and R. Blantz, An analysis of glomerular-tubular balance in the rat proximal tubule, Pfl???gers Archiv European Journal of Physiology, vol.243, issue.Suppl 12, pp.221-228, 1986.
DOI : 10.1007/BF00580680

G. Romano, G. Favret, R. Damato, and E. Bartoli, Proximal reabsorption with changing tubular fluid inflow in rat nephrons, Experimental Physiology, vol.83, issue.1, pp.35-48, 1998.
DOI : 10.1113/expphysiol.1998.sp004090

D. Aronson, M. Kapeliovich, H. Hammerman, and R. Dragu, The Relation between Serum Phosphorus Levels and Clinical Outcomes after Acute Myocardial Infarction, PLoS ONE, vol.301, issue.3, p.58348, 2013.
DOI : 10.1371/journal.pone.0058348.t003

R. Foley, A. Collins, C. Herzog, A. Ishani, and P. Kalra, Serum Phosphorus Levels Associate with Coronary Atherosclerosis in Young Adults, Journal of the American Society of Nephrology, vol.20, issue.2, pp.397-404, 2009.
DOI : 10.1681/ASN.2008020141

F. Lopez, S. Agarwal, M. Grams, L. Loehr, E. Soliman et al., Relation of Serum Phosphorus Levels to the Incidence of Atrial Fibrillation (from the Atherosclerosis Risk In Communities [ARIC] Study), The American Journal of Cardiology, vol.111, issue.6, pp.857-62, 2013.
DOI : 10.1016/j.amjcard.2012.11.045

M. Ketteler, M. Wolf, K. Hahn, and E. Ritz, Phosphate: a novel cardiovascular risk factor, European Heart Journal, vol.42, issue.Suppl 3, pp.1099-101
DOI : 10.1172/JCI46122

K. Park, J. Chang, T. Kim, H. Kim, E. Lee et al., Lower concentrations of serum phosphorus within the normal range could be associated with less calcification of the coronary artery in Koreans with normal renal function, The American Journal of Clinical Nutrition, vol.46, issue.6, pp.1465-70, 2011.
DOI : 10.1016/S0026-0495(97)90212-2

H. Min, J. Jones, and E. Flink, Circadian variations in renal excretion of magnesium, calcium, phosphorus, sodium, and potassium during frequent feeding and fasting. Fed Proc, 1966.

D. Ali, E. Sacchetto, E. Dumontet, L. Carrer, D. Orsonneau et al., Hemolysis influence on twenty-two biochemical parameters measurement], Ann Biol Clin, p.2014

D. Prié, P. Torres, and G. Friedlander, [A new axis of phosphate balance control: fibroblast growth factor 23-Klotho]. Néphrologie Thérapeutique, pp.513-522, 2009.

R. Goetz and M. Mohammadi, Exploring mechanisms of FGF signalling through the lens of structural biology, Nature Reviews Molecular Cell Biology, vol.126, issue.3, pp.166-80, 2013.
DOI : 10.1021/bi011000u

J. Gattineni, C. Bates, K. Twombley, V. Dwarakanath, M. Robinson et al., FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1, American Journal of Physiology-Renal Physiology, vol.297, issue.2, pp.282-291, 2009.
DOI : 10.1074/jbc.M601252200

M. Hu, K. Shiizaki, M. Kuro-o, and O. Moe, Fibroblast Growth Factor 23 and Klotho: Physiology and Pathophysiology of an Endocrine Network of Mineral Metabolism, Annual Review of Physiology, vol.75, issue.1, pp.503-536, 2013.
DOI : 10.1146/annurev-physiol-030212-183727

M. Koizumi, H. Komaba, and M. Fukagawa, Parathyroid Function in Chronic Kidney Disease: Role of FGF23-Klotho Axis, Contrib Nephrol, vol.180, pp.110-133, 2013.
DOI : 10.1159/000346791

H. Olauson and T. Larsson, FGF23 and Klotho in chronic kidney disease, Current Opinion in Nephrology and Hypertension, vol.22, issue.4, pp.397-404
DOI : 10.1097/MNH.0b013e32836213ee

I. Mitu?a, E. Go?embiewska, K. Ciechanowski, and A. Siuda, *FGF-23 and Klotho protein -new markers in chronic kidney disease?]. Pol Merkur Lek Organ Pol Towar Lek, pp.235-243, 2013.

J. Kendrick, A. Cheung, J. Kaufman, T. Greene, W. Roberts et al., FGF-23 Associates with Death, Cardiovascular Events, and Initiation of Chronic Dialysis, Journal of the American Society of Nephrology, vol.22, issue.10, pp.1913-1935, 2011.
DOI : 10.1681/ASN.2010121224

C. Faul, A. Amaral, B. Oskouei, M. Hu, A. Sloan et al., FGF23 induces left ventricular hypertrophy, Journal of Clinical Investigation, vol.121, issue.11, pp.4393-408, 2011.
DOI : 10.1172/JCI46122DS1

URL : http://www.jci.org/articles/view/46122/files/pdf

O. Bijvoet, Relation of plasma phosphate concentration to renal tubular reabsorption of phosphate, Clin Sci, vol.37, issue.1, pp.23-36, 1969.

R. Walton and O. Bijvoet, NOMOGRAM FOR DERIVATION OF RENAL THRESHOLD PHOSPHATE CONCENTRATION, The Lancet, vol.306, issue.7929, pp.309-319, 1975.
DOI : 10.1016/S0140-6736(75)92736-1

A. Habibi, J. Arlet, and K. Stankovic, French guidelines for the management of adult sickle cell disease: 2015 update, Rev Médecine Interne, vol.36, issue.5, pp.5-8, 2015.

J. Haymann, K. Stankovic, and P. Levy, Glomerular Hyperfiltration in Adult Sickle Cell Anemia: A Frequent Hemolysis Associated Feature, Clinical Journal of the American Society of Nephrology, vol.5, issue.5, pp.756-61, 2010.
DOI : 10.2215/CJN.08511109

URL : https://hal.archives-ouvertes.fr/hal-00597593

G. Serjeant, D. Higgs, and I. Hambleton, Elderly Survivors with Homozygous Sickle Cell Disease, New England Journal of Medicine, vol.356, issue.6, pp.642-645, 2007.
DOI : 10.1056/NEJMc066547

P. Jong, S. Van-eps, and L. , Sickle cell nephropathy: New insights into its pathophysiology, Kidney International, vol.27, issue.5, pp.711-718, 1985.
DOI : 10.1038/ki.1985.70

S. Maurel, S. Stojanovic, and K. , Prevalence and Correlates of Metabolic Acidosis among Patients with Homozygous Sickle Cell Disease, Clinical Journal of the American Society of Nephrology, vol.9, issue.4, pp.648-53, 2014.
DOI : 10.2215/CJN.09790913

L. Statius-van-eps, C. Pinedo-veels, G. De-vries, and J. De-koning, Nature of concentrating defect in sickle-cell nephropathy.Microradioangiographic studies, Lancet, vol.1, issue.7644, pp.450-452, 1970.

H. Diamond, A. Meisel, E. Sharon, D. Holden, and A. Cacatian, Hyperuricosuria and increased tubular secretion of urate in sickle cell anemia, The American Journal of Medicine, vol.59, issue.6, pp.796-802, 1975.
DOI : 10.1016/0002-9343(75)90465-9

M. Reynolds, Gout and hyperuricemia associated with sickle-cell Anemia, Seminars in Arthritis and Rheumatism, vol.12, issue.4, pp.404-417, 1983.
DOI : 10.1016/0049-0172(83)90020-3

D. Jong, P. De-jong-van-den, L. Berg, G. Sewrajsingh, H. Schouten et al., Statius van Eps LW. Beta-2-microglobulin in sickle cell anaemia. Evidence of increased tubular reabsorption, Nephron, vol.29, pp.3-4138, 1981.

D. Jong, P. De-jong-van-den, and L. Berg, Statius van Eps LW. The tubular reabsorption of phosphate in sickle-cell nephropathy, Clin Sci Mol Med, vol.55, issue.5, pp.429-463, 1978.

V. Raj, M. Freundlich, and D. Hamideh, Abnormalities in renal tubular phosphate handling in children with sickle cell disease. Pediatr Blood Cancer, pp.2267-70, 2014.

N. Harbi, S. Annobil, F. Abbag, F. Adzaku, W. Bassuni et al., Renal reabsorption of phosphate in children with sickle cell anemia Serum magnesium, phosphate and calcium in Nigerian children with sickle cell disease, 552?4. 14 Oladipo OO, pp.120-123, 1999.

E. Smith, K. Valika, J. Woo, O. Donnell, J. Gordon et al., Serum Phosphate Abnormalities in Sickle Cell Anemia, Experimental Biology and Medicine, vol.168, issue.2, pp.254-262, 1981.
DOI : 10.3181/00379727-168-41269

T. Isakova, H. Xie, and W. Yang, Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease, JAMA, vol.305, issue.23, pp.2432-2441, 201115.
DOI : 10.1001/jama.2011.826

G. Block, T. Hulbert-shearon, N. Levin, and F. Port, Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study, American Journal of Kidney Diseases, vol.31, issue.4, pp.2208-2226, 2004.
DOI : 10.1053/ajkd.1998.v31.pm9531176

G. Block, P. Klassen, J. Lazarus, N. Ofsthun, E. Lowrie et al., Mineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis, Journal of the American Society of Nephrology, vol.15, issue.8, pp.607-624, 1998.
DOI : 10.1097/01.ASN.0000133041.27682.A2

O. Gutiérrez, M. Mannstadt, T. Isakova, J. Rauh-hain, H. Tamez et al., Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis, New England Journal of Medicine, vol.359, issue.6, pp.584-592, 2008.
DOI : 10.1056/NEJMoa0706130

G. Connolly, R. Cunningham, P. Mcnamee, I. Young, and A. Maxwell, Elevated Serum Phosphate Predicts Mortality in Renal Transplant Recipients, Transplantation, vol.87, issue.7, pp.1040-1044, 2009.
DOI : 10.1097/TP.0b013e31819cd122

R. Walton and O. Bijvoet, NOMOGRAM FOR DERIVATION OF RENAL THRESHOLD PHOSPHATE CONCENTRATION, The Lancet, vol.306, issue.7929, pp.309-319, 1975.
DOI : 10.1016/S0140-6736(75)92736-1

R. Asmar, A. Benetos, and J. Topouchian, Assessment of Arterial Distensibility by Automatic Pulse Wave Velocity Measurement : Validation and Clinical Application Studies, Hypertension, vol.26, issue.3
DOI : 10.1161/01.HYP.26.3.485

S. Yoshimura, G. Hasegawa, Y. Yabe, C. Arai, and Y. Kashikura, Pulse wave and arterial elastic property--the principle and the essence of pulse wave velocity method, Kokyu To Junkan, vol.24, issue.5, pp.376-87, 1976.

M. Quiñones, C. Otto, M. Stoddard, A. Waggoner, and W. Zoghbi, Recommendations for quantification of Doppler echocardiography: A report from the Doppler quantification task force of the nomenclature and standards committee of the American Society of Echocardiography, Journal of the American Society of Echocardiography, vol.15, issue.2, pp.167-84, 2002.
DOI : 10.1067/mje.2002.120202

E. Klings, R. Machado, and R. Barst, An Official American Thoracic Society Clinical Practice Guideline: Diagnosis, Risk Stratification, and Management of Pulmonary Hypertension of Sickle Cell Disease, American Journal of Respiratory and Critical Care Medicine, vol.90, issue.6, pp.727-767, 2014.
DOI : 10.1161/CIRCULATIONAHA.110.983866

D. Ali, E. Sacchetto, E. Dumontet, L. Carrer, and D. , Hemolysis influence on twenty-two biochemical parameters measurement, Ann Biol Clin (Paris), vol.72, issue.3, pp.297-311, 2014.

O. Bijvoet, Relation of plasma phosphate concentration to renal tubular reabsorption of phosphate, Clin Sci, vol.37, issue.1, pp.23-36, 1969.

J. Gattineni, C. Bates, and K. Twombley, FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1, American Journal of Physiology-Renal Physiology, vol.297, issue.2
DOI : 10.1074/jbc.M601252200

D. Prié, U. Torres, P. Friedlander, and G. , Le facteur de croissance des fibroblastes 23 et son r??cepteur Klotho, m??decine/sciences, vol.25, issue.5, pp.489-95, 2009.
DOI : 10.1051/medsci/2009255489

G. Saggese, G. Baroncelli, G. Federico, and S. Bertelloni, Effects of Growth Hormone on Phosphocalcium Homeostasis and Bone Metabolism, Hormone Research, vol.44, issue.3, pp.55-63, 1995.
DOI : 10.1159/000184675

H. Olauson and T. Larsson, FGF23 and Klotho in chronic kidney disease, Current Opinion in Nephrology and Hypertension, vol.22, issue.4, pp.397-404, 2013.
DOI : 10.1097/MNH.0b013e32836213ee

I. Mitu?a, E. Go?embiewska, and K. Ciechanowski, FGF-23 and Klotho protein -new markers in chronic kidney disease? Pol Tow Lek, pp.235-243, 2013.

M. Hu, K. Shiizaki, and M. Kuro-o, Fibroblast Growth Factor 23 and Klotho: Physiology and Pathophysiology of an Endocrine Network of Mineral Metabolism, Annual Review of Physiology, vol.75, issue.1, pp.503-536, 2013.
DOI : 10.1146/annurev-physiol-030212-183727

M. Hu, M. Kuro-o, and O. Moe, Klotho and Chronic Kidney Disease, Contrib Nephrol, vol.180, pp.47-63, 2013.
DOI : 10.1159/000346778

D. Prié, P. Torres, and G. Friedlander, Un nouveau syst??me de r??gulation du bilan du phosphate??: Fibroblast Growth Factor 23-Klotho, N??phrologie & Th??rapeutique, vol.5, issue.6, pp.513-522, 2009.
DOI : 10.1016/j.nephro.2009.04.001

O. Peterson, L. Gushwa, and R. Blantz, An analysis of glomerular-tubular balance in the rat proximal tubule, Pfl???gers Archiv European Journal of Physiology, vol.243, issue.Suppl 12, pp.221-228, 1986.
DOI : 10.1007/BF00580680

G. Romano, G. Favret, R. Damato, and E. Bartoli, Proximal reabsorption with changing tubular fluid inflow in rat nephrons, Experimental Physiology, vol.83, issue.1, pp.35-48, 1998.
DOI : 10.1113/expphysiol.1998.sp004090

A. Wasilewska, K. Taranta-janusz, W. Zoch-zwierz, and J. Michaluk-skutnik, Is plasma symmetric dimethylarginine a suitable marker of renal function in children and adolescents?, Scandinavian Journal of Urology and Nephrology, vol.24, issue.1
DOI : 10.1093/ndt/gfn306

M. Marcovecchio, R. Dalton, and C. Turner, Symmetric dimethylarginine, an endogenous marker of glomerular filtration rate, and the risk for microalbuminuria in young people with type 1 diabetes, Archives of Disease in Childhood, vol.95, issue.2, pp.119-143, 2010.
DOI : 10.1136/adc.2009.158394

T. Bensinger and P. Gillette, Hemolysis in Sickle Cell Disease, Archives of Internal Medicine, vol.133, issue.4, pp.624-655, 1974.
DOI : 10.1001/archinte.1974.00320160118010

K. Wood and D. Granger, SICKLE CELL DISEASE: ROLE OF REACTIVE OXYGEN AND NITROGEN METABOLITES, Clinical and Experimental Pharmacology and Physiology, vol.100, issue.9, pp.926-958, 2007.
DOI : 10.1001/jama.289.9.1136

D. Sears, P. Anderson, A. Foy, H. Williams, and W. Crosby, Urinary iron excretion and renal metabolism of hemoglobin in hemolytic diseases, Blood, vol.28, issue.5, pp.708-733, 1966.

S. Babbitt, M. Sutherland, B. Francisco, D. Mendez, and R. Kranz, Mitochondrial cytochrome c biogenesis: no longer an enigma, Trends in Biochemical Sciences, vol.40, issue.8, pp.446-55, 2015.
DOI : 10.1016/j.tibs.2015.05.006

URL : http://europepmc.org/articles/pmc4509832?pdf=render

D. Seigneux, S. Courbebaisse, M. Rutkowski, and J. , Proteinuria Increases Plasma Phosphate by Altering Its Tubular Handling, Journal of the American Society of Nephrology, vol.26, issue.7, pp.1608-1626, 2015.
DOI : 10.1681/ASN.2014010104

J. Van-kuijk, W. Flu, and M. Chonchol, Elevated Preoperative Phosphorus Levels Are an Independent Risk Factor for Cardiovascular Mortality, American Journal of Nephrology, vol.32, issue.2, pp.163-171, 2010.
DOI : 10.1159/000315856

K. Park, J. Chang, and T. Kim, Lower concentrations of serum phosphorus within the normal range could be associated with less calcification of the coronary artery in Koreans with normal renal function, The American Journal of Clinical Nutrition, vol.46, issue.6, pp.1465-70, 2011.
DOI : 10.1016/S0026-0495(97)90212-2

M. Ketteler, M. Wolf, K. Hahn, and E. Ritz, Phosphate: a novel cardiovascular risk factor, European Heart Journal, vol.42, issue.Suppl 3, pp.1099-101, 2013.
DOI : 10.1172/JCI46122

URL : https://academic.oup.com/eurheartj/article-pdf/34/15/1099/17894702/ehs247.pdf

F. Lopez, S. Agarwal, and M. Grams, Relation of Serum Phosphorus Levels to the Incidence of Atrial Fibrillation (from the Atherosclerosis Risk In Communities [ARIC] Study), The American Journal of Cardiology, vol.111, issue.6, pp.857-62, 2013.
DOI : 10.1016/j.amjcard.2012.11.045

R. Foley, A. Collins, C. Herzog, A. Ishani, and P. Kalra, Serum Phosphorus Levels Associate with Coronary Atherosclerosis in Young Adults, Journal of the American Society of Nephrology, vol.20, issue.2, pp.397-404, 2009.
DOI : 10.1681/ASN.2008020141

J. Kendrick, A. Cheung, and J. Kaufman, FGF-23 Associates with Death, Cardiovascular Events, and Initiation of Chronic Dialysis, Journal of the American Society of Nephrology, vol.22, issue.10, pp.1913-1935, 2011.
DOI : 10.1681/ASN.2010121224

C. Faul, A. Amaral, and B. Oskouei, FGF23 induces left ventricular hypertrophy, Journal of Clinical Investigation, vol.121, issue.11, pp.4393-408, 2011.
DOI : 10.1172/JCI46122DS1

URL : http://www.jci.org/articles/view/46122/files/pdf

M. Gladwin, V. Sachdev, and M. Jison, Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease, New England Journal of Medicine, vol.350, issue.9, pp.886-95, 2004.
DOI : 10.1056/NEJMoa035477

E. Klings, R. Machado, and R. Barst, An Official American Thoracic Society Clinical Practice Guideline: Diagnosis, Risk Stratification, and Management of Pulmonary Hypertension of Sickle Cell Disease, American Journal of Respiratory and Critical Care Medicine, vol.90, issue.6, pp.727-767, 2014.
DOI : 10.1161/CIRCULATIONAHA.110.983866

C. Minniti, C. Sable, and A. Campbell, Elevated tricuspid regurgitant jet velocity in children and adolescents with sickle cell disease: association with hemolysis and hemoglobin oxygen desaturation, Haematologica, vol.94, issue.3, pp.340-347, 2009.
DOI : 10.3324/haematol.13812

H. Bunn, D. Nathan, and G. Dover, Pulmonary hypertension and nitric oxide depletion in sickle cell disease, Blood, vol.116, issue.5, pp.687-92, 2010.
DOI : 10.1182/blood-2010-02-268193

K. Hassell, Pulmonary hypertension, tricuspid regurgitant velocity screening, and the nitric oxide pathway. Hematol Educ Program Am Soc Hematol, pp.419-445, 2011.

K. Potoka and M. Gladwin, Vasculopathy and pulmonary hypertension in sickle cell disease, American Journal of Physiology-Lung Cellular and Molecular Physiology, vol.277, issue.4, pp.314-338, 2015.
DOI : 10.1152/ajpheart.00296.2012

J. Belcher, C. Chen, and J. Nguyen, Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease, Blood, vol.123, issue.3, pp.377-90, 2014.
DOI : 10.1182/blood-2013-04-495887

K. Nath and Z. Katusic, Vasculature and Kidney Complications in Sickle Cell Disease, Journal of the American Society of Nephrology, vol.23, issue.5, pp.781-785, 2012.
DOI : 10.1681/ASN.2011101019

I. Cabrita, A. Mohammed, and M. Layton, The association between tricuspid regurgitation velocity and 5-year survival in a North West London population of patients with sickle cell disease in the United Kingdom, British Journal of Haematology, vol.92, issue.Suppl. 6, pp.400-408, 2013.
DOI : 10.3324/haematol.10937

E. Schepers, G. Glorieux, and L. Dou, Guanidino Compounds as Cause of Cardiovascular Damage in Chronic Kidney Disease: An in vitro Evaluation, Blood Purification, vol.30, issue.4, pp.277-87, 2010.
DOI : 10.1159/000320765

URL : https://hal.archives-ouvertes.fr/hal-01610436

M. Ivanova, C. Artusi, G. Boffa, M. Zaninotto, and M. Plebani, HPLC determination of plasma dimethylarginines: Method validation and preliminary clinical application, Clinica Chimica Acta, vol.411, issue.21-22, pp.21-221632, 2010.
DOI : 10.1016/j.cca.2010.06.001

P. Landburg, T. Teerlink, and B. Biemond, Plasma asymmetric dimethylarginine concentrations in sickle cell disease are related to the hemolytic phenotype, Blood Cells, Molecules, and Diseases, vol.44, issue.4, pp.229-261, 2010.
DOI : 10.1016/j.bcmd.2010.02.005

M. El-shanshory, I. Badraia, A. Donia, A. El-hameed, F. Mabrouk et al., Asymmetric dimethylarginine levels in children with sickle cell disease and its correlation to tricuspid regurgitant jet velocity, European Journal of Haematology, vol.365, issue.1, pp.55-61
DOI : 10.1056/NEJMoa1005565

D. 'alecy, L. Billecke, and S. , Massive quantities of asymmetric dimethylarginine (ADMA) are incorporated in red blood cell proteins and may be released by proteolysis following hemolytic stress, Blood Cells, Molecules, and Diseases, vol.45, issue.1, p.40, 2010.
DOI : 10.1016/j.bcmd.2010.03.004

P. Landburg, T. Teerlink, and B. Biemond, Plasma asymmetric dimethylarginine concentrations in sickle cell disease are related to the hemolytic phenotype, Blood Cells, Molecules, and Diseases, vol.44, issue.4, pp.229-261, 2010.
DOI : 10.1016/j.bcmd.2010.02.005

G. Kato, Z. Wang, R. Machado, W. Blackwelder, J. Taylor et al., Endogenous nitric oxide synthase inhibitors in sickle cell disease: abnormal levels and correlations with pulmonary hypertension, desaturation, haemolysis, organ dysfunction and death, British Journal of Haematology, vol.358, issue.Suppl. 1, pp.506-519, 2009.
DOI : 10.1161/01.CIR.99.24.3092

P. Landburg, T. Teerlink, F. Muskiet, A. Duits, and J. Schnog, CURAMA study group. Plasma concentrations of asymmetric dimethylarginine, an endogenous nitric oxide synthase inhibitor, are elevated in sickle cell patients but do not increase further during painful crisis

J. Schnog, T. Teerlink, F. Van-der-dijs, A. Duits, F. Muskiet et al., Plasma levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, are elevated in sickle cell disease, Annals of Hematology, vol.82, issue.5, pp.282-288, 2005.
DOI : 10.1007/s00277-004-0983-3

M. El-shanshory, I. Badraia, A. Donia, A. El-hameed, F. Mabrouk et al., Asymmetric dimethylarginine levels in children with sickle cell disease and its correlation to tricuspid regurgitant jet velocity, European Journal of Haematology, vol.365, issue.1, pp.55-61, 2013.
DOI : 10.1056/NEJMoa1005565

S. Pullamsetti, L. Kiss, and H. Ghofrani, Increased levels and reduced catabolism of asymmetric and symmetric dimethylarginines in pulmonary hypertension, The FASEB Journal, vol.19, issue.9, pp.1175-1182, 2005.
DOI : 10.1096/fj.04-3223fje

R. Falk, J. Scheinman, G. Phillips, E. Orringer, A. Johnson et al., Prevalence and Pathologic Features of Sickle Cell Nephropathy and Response to Inhibition of Angiotensin-Converting Enzyme, New England Journal of Medicine, vol.326, issue.14, pp.910-952, 1992.
DOI : 10.1056/NEJM199204023261402

L. Foucan, V. Bourhis, J. Bangou, L. Me´rault, M. Etienne-julan et al., A Randomized Trial of Captopril for Microalbuminuria in Normotensive Adults with Sickle Cell Anemia, The American Journal of Medicine, vol.104, issue.4, pp.339-342, 1998.
DOI : 10.1016/S0002-9343(98)00056-4